AstraZeneca is listing in New York, as Big Pharma balances the huge U.S. market with China’s tempting innovation

by | February 1, 2026 5:22 pm | US Markets

AstraZeneca announces multibillion dollar investments in China as Big Pharma is increasingly looking east for innovation.